Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Kantarjian HM, Paul S. Hepatitis C: When high drug prices preclude patient benefit. Cancer 2018;124:1644-1646. [PMID: 29486061 DOI: 10.1002/cncr.31292] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2017] [Revised: 10/27/2017] [Accepted: 11/02/2017] [Indexed: 01/08/2023]

For:	Kantarjian HM, Paul S. Hepatitis C: When high drug prices preclude patient benefit. Cancer 2018;124:1644-1646. [PMID: 29486061 DOI: 10.1002/cncr.31292] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2017] [Revised: 10/27/2017] [Accepted: 11/02/2017] [Indexed: 01/08/2023]

Number

Cited by Other Article(s)

Soriano V, Tefferi A. Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges. Cancer 2018;124:1647-1649. [PMID: 29486060 DOI: 10.1002/cncr.31291] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2017] [Accepted: 01/13/2018] [Indexed: 12/12/2022]